Skip to main content
. 2017 Mar 13;64(8):1017–1025. doi: 10.1093/cid/cix016

Figure 1.

Figure 1.

Time course of posttreatment adverse events (AEs). The histogram shows the total number of AEs recorded for subjects in the diethylcarbamazine (DEC; black bar) and ivermectin (IVM; gray bar) groups for each time point.